Join our email list...
RSS Feed (medpagetoday.com)
RSS General- Gupta Guide: Cancer Patients Poorly Served by Online Nutrition Info
When it comes to directing cancer patients to solid nutritional recommendations online, physicians are likely to find themselves at a loss. (...) - Clinical Notes: Users Deem E-Cigs Safer
Most electronic cigarettes smokers surveyed believe they're less dangerous than regular cigarettes and will help them stop smoking. Also this week: Eli Lilly pulls the plug on a novel rheumatoid arthr (...)
Join us on May 5th for Cinco de Drinko!
Click here for more details!
Welcome to our site…
Welcome to lymphosite.org, the home of Medical Students for Lymphoma Research (MSLR). We are a 501(c)(3) nonprofit organization dedicated to supporting lymphoma research. Our organization is based in Denver, Colorado and was founded by a group of aspiring physicians attending the University of Colorado School of Medicine. Three of our classmates have suffered from lymphoma, so we were inspired to fight lymphoma together. Please take a moment to browse our site and learn more about us, especially the News and Events Page for the latest blogs and pictures!
A message from our founder…
At the end of my first semester of medical school I was diagnosed with Hodgkin’s Lymphoma. Fortunately, my disease was caught early and was a subtype that responded well to therapy. I underwent chemotherapy with a relatively new drug and radiation. As of May 26, 2009 I have been cancer-free. However, I was distressed when I discovered that just 50 years ago Hodgkin’s Lymphoma was not known to be curable. If I had been born only a couple of generations earlier, the disease would have almost certainly killed me. While great advancements have been made in the field of Hodgkin’s Lymphoma over the last few decades, there are many types of lymphoma that still carry a poor prognosis. This group was started with the purpose of improving the outcome of patients with lymphoma by both funding lymphoma research and by influencing bright future physicians to pursue careers in the field of oncology. I hope that our group’s efforts, combined with current investigation of the disease, will give life and hope to future lymphoma patients, as the diligent work of researchers and physicians in the past has given me.
- Peter K. Moore, co-president and co-founder